The Report Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By
Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel
Needle Free), and Segment Forecasts, 2018 – 2025
The global needle-free drug delivery device
market size is poised to reach USD 16.27 billion by 2025, according to a
new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during
the forecast period. Rising usage of injections in healthcare settings such as
hospitals, clinics, and ambulatory surgical centers has led to spread of
infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in
developing countries. This acts as a key driver for the needle-less drug
delivery devices industry. Furthermore, rising collaborations between market
players is further likely to increase competitiveness of this market. For
instance, PharmaJet and Mundipharma entered into a partnership in 2018 for
distributing its needle free injectors over 120 markets globally.
Moreover,
technological advancements in healthcare are expected to open new avenues for
market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy.
For instance, polycarbonate materials are being utilized in needle free
injectors owing to their advantages such as design flexibility, toughness,
light weight, and process ability. The most recent example of such technology
is needle-free injection insulin delivery device manufactured by QS Medical
Technology Co. (QS) in September 2018.
Access Research Report of Needle-Free Drug Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/needle-free-drug-delivery-devices-market
Further key findings
from the report suggest:
· Novel needle-less devices accounted for a significant
share of more than 25.00% in 2017 owing to their wide array of applications
· Based on applications, the vaccine delivery segment is
estimated to exhibit a lucrative growth rate over the forecast period due to its
increasing usage for pediatric patients
· North America held the dominant share in the global arena
in 2017, due to favorable government insurance policies and increased
investments in R&D by healthcare companies
· For instance, In May 2018, U.S. Congress approved “right
to try” bill where patients can try unproven medical treatments and devices in
case of serious illness such as orphan diseases, including NETs
· The Asia Pacific needle-free medication transportation
devices industry is anticipated to witness significant growth during the same
period due to rising healthcare expenditure and growing investments by many
companies in the healthcare sector
· Additionally, several countries in this region are
implementing laws that cater to adoption of medical devices. For instance, the
Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012,
in which most of the medical devices in Korea were made duty free
· Some of the key companies present in the market are
Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M
Company
· Industry participants are involved in extensive research
activities to develop novel needless drug delivery injectors for applications
such as pain management, insulin drug delivery, and vaccines delivery.
Grand View Research has segmented the global needle-free
medicine delivery device market on the basis of technology, application, and
region:
Needle-Free Drug
Delivery Device Technology Outlook (Revenue, USD Million, 2014 - 2025)
·
Jet injectors
·
Inhaler technology
·
Transdermal patch technology
·
Novel needle-free technologies
Needle-Free Drug
Delivery Device Application Outlook (Revenue, USD Million, 2014 - 2025)
·
Others Vaccine delivery
·
Pain management
·
Insulin delivery for diabetes
·
Pediatric injections
·
Others
Needle-Free Drug
Delivery Device Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o U.K.
o Germany
·
Asia Pacific
o Japan
o China
o India
·
Latin America
o Mexico
o
Brazil
·
Middle East & Africa
o South
Africa
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range
of industries, from technology to chemicals, materials and healthcare.
